XENO (Xeno Transplants) Common Stock: $0.04 Mil (As of Mar. 2008)


What is Xeno Transplants Common Stock?

Xeno Transplants XENO Common Stock is $0.04 Mil as of Mar. 2008.

Xeno Transplants's quarterly common stock stayed the same from Sep. 2007 ($0.04 Mil) to Dec. 2007 ($0.04 Mil) and stayed the same from Dec. 2007 ($0.04 Mil) to Mar. 2008 ($0.04 Mil).

Xeno Transplants's annual common stock increased from Jun. 2005 ($0.01 Mil) to Jun. 2006 ($0.02 Mil) and increased from Jun. 2006 ($0.02 Mil) to Jun. 2007 ($0.04 Mil).

Xeno Transplants Common Stock Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants Common Stock Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
Common Stock
0.01 0.02 0.04

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.04 0.04 0.04 0.04

Xeno Transplants Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.04 Mil mean?
Xeno Transplants (XENO) has a Common Stock of $0.04 Mil as of Mar. 2008. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' Common Stock too high?
Xeno Transplants' current Common Stock is $0.04 Mil.
How does Xeno Transplants' Common Stock compare to PRTX and GWSN?
Xeno Transplants' Common Stock of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current Common Stock is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current Common Stock of $0.04 Mil. The current Common Stock is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Xeno Transplants (XENO), the current Common Stock is $0.04 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.